HVTN 303
This study is assessing the safety, tolerability, and immune response of an adjuvanted HIV-1 fusion peptide conjugated vaccines in healthy, HIV negative adults between the ages of 18 to 50. This study is currently enrolling participants.
SARS-CoV-2 Household Transmission
/in Enrollment CompleteThis study is assessing whether COVID-19 vaccines reduce SARS-CoV-2 transmission within households and how readily SARS-CoV2 transmits to household members in an effort to determine better quarantine measures. This study is currently enrolling participants.
HVTN 302
/in Enrollment CompleteThis study is assessing the safety and immune response of 3 experimental mRNA HIV vaccines in healthy, HIV negative adults between the ages of 18 to 55. This study is currently enrolling participants.
vYF02
/in Enrollment CompleteThis study is comparing the immunogenicity and safety of an investigational yellow fever vaccine with the previously approved YF-VAX vaccine. The main purpose of the study is to determine if the study vaccine is safe and creates comparable immune responses to that of the YF-VAX vaccine. This study is currently enrolling.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu